HLA class I expression and HPV‐16 sequences in premalignant and malignant lesions of the cervix

Authors:

Abstract
A series of 10 normal cervix epithelia, 38 condylomas, 17 CIN (cervical intraepithelial neoplasm) I/II (low‐grade CIN), 10 CIN III (high‐grade CIN), 27 squamous cell carcinomas and 7 adenocarcinomas of the cervix were studied in paraffin‐embedded sections for the expression of MHC class I antigens, using antibodies against HLA antigens and the immunoperoxidase technique. A PCR technique was also used to evaluate the presence of HPV‐16 DNA. All samples from normal tissue, benign, premalignant and CIN III lesions expressed HLA class I antigens. However, 15% of the invasive carcinomas completely lacked HLA‐B and HLA‐C antigen expression, 20% presented a heterogeneous pattern and 2 cases lacked HLA‐B and HLA‐C heavy chain but retained β,‐microglobulin. MHC class I antigen expression on tumors was compared with clinicalpathological parameters. The absence of expression of HLA class I molecules was significantly associated with the Glanz histoprognostic index of malignancy. HPV‐16 sequences were detected in 60% of the condylomas, 88% of the CIN I/II, 80% of the CIN III and 82% of the cervical carcinomas. Eight‐six per cent of the tumors expressing HLA class I antigen presented HPV‐16, whereas only 40% of the nonexpressing tumors did. Our results lead us to the following conclusions: a) HLA class I losses occurred when the tumor became invasive, and in tumors of a more aggressive histological type; b) The presence of HPV‐16 was associated with tumors expressing HLA class I antigens.

This publication has 28 references indexed in Scilit: